{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:44:02Z","timestamp":1786992242993,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274193"],"award-info":[{"award-number":["82274193"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82422077"],"award-info":[{"award-number":["82422077"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024B1515020093"],"award-info":[{"award-number":["2024B1515020093"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515140027"],"award-info":[{"award-number":["2022A1515140027"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jep.2025.120350","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:08:23Z","timestamp":1754438903000},"page":"120350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"PA","title":["Assessment of potential disease-drug interactions when prescribed Fuzi for rheumatoid arthritis treatment, with focus on the pharmacokinetics of aconitine, mesaconitine, and hypaconitine"],"prefix":"10.1016","volume":"353","author":[{"given":"Yating","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaocui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2012-7266","authenticated-orcid":false,"given":"Ling","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jep.2025.120350_bib1","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1111\/bcp.16175","article-title":"Inflammation-mediated drug interactions of olokizumab and cytochrome P450 activities in patients with rheumatoid arthritis","volume":"90","author":"Agachi","year":"2024","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.jep.2025.120350_bib2","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1124\/dmd.107.015511","article-title":"Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes","volume":"35","author":"Aitken","year":"2007","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.jep.2025.120350_bib3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/1389200219666181003142036","article-title":"Drug-drug interactions of P-gp substrates unrelated to CYP metabolism","volume":"20","author":"Akamine","year":"2019","journal-title":"Curr. Drug Metabol."},{"issue":"3","key":"10.1016\/j.jep.2025.120350_bib4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0378-8741(81)90001-5","article-title":"Arrow poisons in China. Part II. Aconitum--botany, chemistry, and pharmacology","volume":"4","author":"Bisset","year":"1981","journal-title":"J. Ethnopharmacol."},{"issue":"5","key":"10.1016\/j.jep.2025.120350_bib5","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nprot.2007.173","article-title":"Collagen-induced arthritis","volume":"2","author":"Brand","year":"2007","journal-title":"Nat. Protoc."},{"issue":"5","key":"10.1016\/j.jep.2025.120350_bib6","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/0300985815588612","article-title":"Mouse models of rheumatoid arthritis","volume":"52","author":"Caplazi","year":"2015","journal-title":"Vet. Pathol."},{"issue":"3","key":"10.1016\/j.jep.2025.120350_bib7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/03602532.2018.1497645","article-title":"Alterations of drug-metabolizing enzymes and transporters under diabetic conditions: what is the potential clinical significance?","volume":"50","author":"Chen","year":"2018","journal-title":"Drug Metab. Rev."},{"issue":"7","key":"10.1016\/j.jep.2025.120350_bib8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2165\/11597470-000000000-00000","article-title":"Aconite poisoning over 5 years: a case series in Hong Kong and lessons towards herbal safety","volume":"35","author":"Chen","year":"2012","journal-title":"Drug Saf."},{"key":"10.1016\/j.jep.2025.120350_bib9","first-page":"200","volume":"\u2160","author":"Commission","year":"2020"},{"issue":"7","key":"10.1016\/j.jep.2025.120350_bib10","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/jcph.1093","article-title":"Disease-drug interactions in inflammatory states via effects on CYP-mediated drug clearance","volume":"58","author":"Coutant","year":"2018","journal-title":"J. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.jep.2025.120350_bib67","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.chroma.2008.10.082","article-title":"Qualitative and quantitative analysis of aconitine-type and lipo-alkaloids of Aconitum carmichaelii roots","volume":"1216","author":"Csupor","year":"2009","journal-title":"J. Chromatogr. A"},{"issue":"10416","key":"10.1016\/j.jep.2025.120350_bib11","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","article-title":"Rheumatoid arthritis","volume":"402","author":"Di Matteo","year":"2023","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jep.2025.120350_bib12","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/cpt.1115","article-title":"Disease-associated changes in drug transporters may impact the pharmacokinetics And\/Or toxicity of drugs: a white paper from the international transporter consortium","volume":"104","author":"Evers","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jep.2025.120350_bib13","series-title":"Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers","year":"2005"},{"key":"10.1016\/j.jep.2025.120350_bib15","volume":"\u2160","author":"Guo","year":"2023"},{"issue":"Pt 2","key":"10.1016\/j.jep.2025.120350_bib16","article-title":"The intestinal absorption of triptolide for the treatment of rheumatoid arthritis is mediated by transporters","volume":"143","author":"Guo","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.jep.2025.120350_bib17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2174\/1389200216666150803144631","article-title":"Drug metabolism and pharmacokinetic diversity of Ranunculaceae medicinal compounds","volume":"16","author":"Hao","year":"2015","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.jep.2025.120350_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116160","article-title":"Chemical constituents, pharmacological effects, toxicology, processing and compatibility of fuzi (lateral root of Aconitum carmichaelii debx): a review","volume":"307","author":"He","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.jep.2025.120350_bib19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ddr.21918","article-title":"Approaches to minimize the effects of P-glycoprotein in drug transport: a review","volume":"83","author":"Husain","year":"2022","journal-title":"Drug Dev. Res."},{"issue":"6","key":"10.1016\/j.jep.2025.120350_bib68","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1021\/np300225t","article-title":"Diterpenoid alkaloids from the lateral root of Aconitum carmichaelii","volume":"75","author":"Jiang","year":"2012","journal-title":"J. Nat. Prod."},{"issue":"14","key":"10.1016\/j.jep.2025.120350_bib20","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.scib.2023.06.027","article-title":"Sinomenine ameliorates rheumatoid arthritis by modulating tryptophan metabolism and activating aryl hydrocarbon receptor via gut microbiota regulation","volume":"68","author":"Jiang","year":"2023","journal-title":"Sci. Bull. (Beijing)"},{"issue":"12","key":"10.1016\/j.jep.2025.120350_bib21","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1016\/j.apsb.2021.05.030","article-title":"Altered cisplatin pharmacokinetics during nonalcoholic steatohepatitis contributes to reduced nephrotoxicity","volume":"11","author":"Jilek","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"11","key":"10.1016\/j.jep.2025.120350_bib22","doi-asserted-by":"crossref","first-page":"8669","DOI":"10.1007\/s11033-020-05909-2","article-title":"Pro-inflammatory cytokine response pre-dominates immuno-genetic pathway in development of rheumatoid arthritis","volume":"47","author":"Krishna Priya","year":"2020","journal-title":"Mol. Biol. Rep."},{"issue":"3","key":"10.1016\/j.jep.2025.120350_bib23","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1124\/dmd.108.023630","article-title":"Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6","volume":"37","author":"Le Vee","year":"2009","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.jep.2025.120350_bib24","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s40262-016-0462-8","article-title":"Disease-drug interaction of sarilumab and simvastatin in patients with rheumatoid arthritis","volume":"56","author":"Lee","year":"2017","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.jep.2025.120350_bib25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s12276-025-01401-8","article-title":"Rheumatoid arthritis severity is mediated by crosstalk between synoviocytes and mature osteoclasts through a calcium and cytokine feedback loop","volume":"57","author":"Lee","year":"2025","journal-title":"Exp. Mol. Med."},{"issue":"6","key":"10.1016\/j.jep.2025.120350_bib26","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/cpt.2146","article-title":"Impact of acute inflammation on cytochromes P450 activity assessed by the Geneva cocktail","volume":"109","author":"Lenoir","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.jep.2025.120350_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13075-022-02945-0","article-title":"Rheumatoid arthritis sera antibodies to citrullinated collagen type II bind to joint cartilage","volume":"24","author":"Li","year":"2022","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jep.2025.120350_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2023.113989","article-title":"Clinical poisoning events involving yunaconitine May be highly correlated with metabolism-based interactions: a critical role of CYP3A4","volume":"179","author":"Li","year":"2023","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jep.2025.120350_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115332","article-title":"Mdr1a, bcrp and Mrp2 regulate the efficacy and toxicity of mesaconitine and hypaconitine by altering their tissue accumulation and in vivo residence","volume":"409","author":"Li","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jep.2025.120350_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116024","article-title":"Bulleyaconitine A is a sensitive substrate and competitive inhibitor of CYP3A4: one of the possible explanations for clinical adverse reactions","volume":"445","author":"Li","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"4","key":"10.1016\/j.jep.2025.120350_bib31","doi-asserted-by":"crossref","DOI":"10.1186\/ar4605","article-title":"Type II collagen antibody response is enriched in the synovial fluid of rheumatoid joints and directed to the same major epitopes as in collagen induced arthritis in Primates and mice","volume":"16","author":"Lindh","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.jep.2025.120350_bib32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","article-title":"On the dependency of cellular protein levels on mRNA abundance","volume":"165","author":"Liu","year":"2016","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.jep.2025.120350_bib33","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1124\/dmd.108.020859","article-title":"Closing the gaps: a full scan of the intestinal expression of p-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in Male and female rats","volume":"36","author":"MacLean","year":"2008","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.jep.2025.120350_bib34","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/ard.52.3.232","article-title":"Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity","volume":"52","author":"Madhok","year":"1993","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.jep.2025.120350_bib35","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1517\/17425255.2.6.875","article-title":"Species differences between mouse, rat, dog, monkey and human CYP-Mediated drug metabolism, inhibition and induction","volume":"2","author":"Martignoni","year":"2006","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"23","key":"10.1016\/j.jep.2025.120350_bib36","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jep.2025.120350_bib37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2018.02.006","article-title":"Efficacy of constant long-term delivery of YM-58483 for the treatment of rheumatoid arthritis","volume":"824","author":"Miyoshi","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.jep.2025.120350_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"issue":"5","key":"10.1016\/j.jep.2025.120350_bib39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10928-023-09867-7","article-title":"Physiologically-based pharmacokinetic modeling to predict drug-drug interaction of enzalutamide with combined P-gp and CYP3A substrates","volume":"50","author":"Otsuka","year":"2023","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.jep.2025.120350_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1423884","article-title":"Fu-zi decoction attenuate rheumatoid arthritis in vivo and in vitro by modulating RANK\/RANKL signaling pathway","volume":"15","author":"Pan","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.jep.2025.120350_bib41","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.3390\/ijms15034965","article-title":"P-glycoprotein and drug resistance in systemic autoimmune diseases","volume":"15","author":"Picchianti-Diamanti","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jep.2025.120350_bib42","volume":"\u2161","author":"Piper","year":"2017"},{"issue":"5","key":"10.1016\/j.jep.2025.120350_bib43","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/clpt.2011.35","article-title":"Disease-drug-drug interaction involving tocilizumab and simvastatin in patients with rheumatoid arthritis","volume":"89","author":"Schmitt","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.jep.2025.120350_bib44","first-page":"825","article-title":"Aconite poisoning","volume":"34","author":"Singh","year":"1986","journal-title":"J. Assoc. Phys. India"},{"issue":"1","key":"10.1016\/j.jep.2025.120350_bib45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jep.2009.07.031","article-title":"Aconitum in traditional Chinese medicine: a valuable drug or an unpredictable risk?","volume":"126","author":"Singhuber","year":"2009","journal-title":"J. Ethnopharmacol."},{"issue":"5","key":"10.1016\/j.jep.2025.120350_bib46","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrrheum.2015.8","article-title":"Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges","volume":"11","author":"Smolen","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.jep.2025.120350_bib47","doi-asserted-by":"crossref","first-page":"41","DOI":"10.14712\/fb2023069020041","article-title":"Pathogenesis of collagen-induced arthritis: role of immune cells with associated cytokines and antibodies, comparison with rheumatoid arthritis","volume":"69","author":"\u0160teigerov\u00e1","year":"2023","journal-title":"Folia Biol. (Praha)"},{"issue":"12\u201313","key":"10.1016\/j.jep.2025.120350_bib48","first-page":"1017","article-title":"Clinical aspects of aconitum preparations","volume":"81","author":"Tai","year":"2015","journal-title":"Planta Med."},{"issue":"9","key":"10.1016\/j.jep.2025.120350_bib49","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1055\/s-2003-43217","article-title":"8-O-cinnamoylneoline, a new alkaloid from the flower buds of Aconitum carmichaeli and its toxic and analgesic activities","volume":"69","author":"Taki","year":"2003","journal-title":"Planta Med."},{"issue":"1","key":"10.1016\/j.jep.2025.120350_bib50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.toxlet.2011.01.019","article-title":"Involvement of CYP3A4\/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymes","volume":"202","author":"Tang","year":"2011","journal-title":"Toxicol. Lett."},{"issue":"8","key":"10.1016\/j.jep.2025.120350_bib51","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.1780250801","article-title":"Collagen arthritis as a relevant model for rheumatoid arthritis","volume":"25","author":"Trentham","year":"1982","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.jep.2025.120350_bib52","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5493\/wjem.v5.i4.225","article-title":"Disease control by regulation of P-glycoprotein on lymphocytes in patients with rheumatoid arthritis","volume":"5","author":"Tsujimura","year":"2015","journal-title":"World J. Exp. Med."},{"key":"10.1016\/j.jep.2025.120350_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115838","article-title":"Ethnopharmacological use, pharmacology, toxicology, phytochemistry, and progress in Chinese crude drug processing of the lateral root of Aconitum carmichaelii debeaux. (fuzi): a review","volume":"301","author":"Wang","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2025.120350_bib69","doi-asserted-by":"crossref","DOI":"10.1111\/bju.16812","article-title":"Renal pelvic pressure drives fluid absorption in mini-percutaneous nephrolithotomy: a quantitative model for absorption rate","author":"Wang","year":"2025","journal-title":"BJU Int."},{"issue":"4","key":"10.1016\/j.jep.2025.120350_bib54","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1254\/jphs.94.459","article-title":"Expression of CYP3A4 mRNA is correlated with CYP3A4 protein level and metabolic activity in human liver","volume":"94","author":"Watanabe","year":"2004","journal-title":"J. Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.jep.2025.120350_bib55","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/clpt.2014.129","article-title":"Functional gene variants of CYP3A4","volume":"96","author":"Werk","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.jep.2025.120350_bib56","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1124\/dmd.118.082065","article-title":"Associations between cytokine levels and CYP3A4 phenotype in patients with rheumatoid arthritis","volume":"46","author":"Wollmann","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jep.2025.120350_bib57","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.phymed.2018.03.001","article-title":"A systematic review of pharmacokinetic studies on herbal drug fuzi: implications for fuzi as personalized medicine","volume":"44","author":"Wu","year":"2018","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.jep.2025.120350_bib58","first-page":"72","article-title":"128 cases of rheumatoid arthritis treated with fuzi","volume":"6","year":"2015","journal-title":"Traditional Chin. Med. Rehab."},{"issue":"10","key":"10.1016\/j.jep.2025.120350_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10100391","article-title":"Relationships between the toxicities of Radix aconiti lateralis preparata (fuzi) and the toxicokinetics of its main diester-diterpenoid alkaloids","volume":"10","author":"Yang","year":"2018","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.jep.2025.120350_bib60","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3109\/00498254.2010.524950","article-title":"Characterization of metabolites and human P450 isoforms involved in the microsomal metabolism of mesaconitine","volume":"41","author":"Ye","year":"2011","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1016\/j.jep.2025.120350_bib61","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.toxlet.2011.04.015","article-title":"Microsomal cytochrome P450-mediated metabolism of hypaconitine, an active and highly toxic constituent derived from aconitum species","volume":"204","author":"Ye","year":"2011","journal-title":"Toxicol. Lett."},{"issue":"2\u20133","key":"10.1016\/j.jep.2025.120350_bib62","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.toxlet.2012.11.011","article-title":"The role of efflux transporters on the transport of highly toxic Aconitine, mesaconitine, hypaconitine, and their hydrolysates, as determined in cultured Caco-2 and transfected MDCKII cells","volume":"216","author":"Ye","year":"2013","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.jep.2025.120350_bib63","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.jep.2025.120350_bib64","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/s41565-018-0254-4","article-title":"Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis","volume":"13","author":"Zhang","year":"2018","journal-title":"Nat. Nanotechnol."},{"issue":"23","key":"10.1016\/j.jep.2025.120350_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312808","article-title":"Cytochrome P450 enzymes and drug metabolism in humans","volume":"22","author":"Zhao","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jep.2025.120350_bib66","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jep.2014.11.043","article-title":"A review on phytochemistry and pharmacological activities of the processed lateral root of Aconitum carmichaelii debeaux","volume":"160","author":"Zhou","year":"2015","journal-title":"J. Ethnopharmacol."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874125010426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874125010426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T17:46:09Z","timestamp":1777571169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874125010426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":68,"alternative-id":["S0378874125010426"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2025.120350","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of potential disease-drug interactions when prescribed Fuzi for rheumatoid arthritis treatment, with focus on the pharmacokinetics of aconitine, mesaconitine, and hypaconitine","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2025.120350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120350"}}